Blue Mesa Health Inc. Achieves 'Preliminary' Recognition Status From CDC

NEW YORK, March 13, 2018 /PRNewswire/ -- Blue Mesa Health Inc. ("Blue Mesa"), a US-based company with offices in New York and Vancouver, is pleased to announce that it has achieved Preliminary recognition status under the Centers for Disease Control and Prevention (CDC) Diabetes Prevention Recognition Program (DPRP). The DPRP recognizes organization that have demonstrated the ability to effectively deliver a proven type 2 diabetes prevention-focused lifestyle change program.

Blue Mesa is one of a select few digital or 'OnLine' providers (the Transform program is delivered remotely using a combination of home health monitoring technology, a smartphone app and remote coaching services) to have achieved preliminary of full recognition. Based on the recently updated 2018 standards, the DPRP awards three categories of recognition: pending, preliminary and full. The achievement of preliminary recognition is a significant achievement for Blue Mesa on the path to full recognition.

Blue Mesa Health Inc. ("Blue Mesa") released its digital Diabetes Prevention Program ("DPP") Transform to the US enterprise payer market. The program is designed to address the problem of rising chronic disease-related health costs in the US, where approximately one-third of all individuals are prediabetic. The program combines software, home health monitoring via wireless scales, activity trackers, and remote health coaching to guide participants through a clinically validated twelve-month program, the goal of which is for participants to lose approximately 5-7% of their body weight and reduce type 2 diabetes risk by 58%.

"We launched our program in 2016 and have been very pleased to work closely with the CDC on submitting our data and paving the path to full recognition for our program," said Blue Mesa Health Inc. Chief Health Officer and Co-Founder Misa Nuccio, MPH. "This is another milestone for our company as we continue to expand our program to more participants in the US and around the world."